Výsledky vyhledávání - "Anne-Marie Rasmussen"

The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study

Autor: Anne-Marie Rasmussen, Frida Bugge Askeland, Fredrik Schjesvold

Publikováno v: Hemato. 1:36-48

The treatment approach for multiple myeloma (MM) has changed in recent years. After the approval of maintenance treatment after stem cell transplant in younger patients, the paradigm of continuous treatment is now prevailing in all clinical situation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cb5007046a3bc6b6a09cd69b8329977
https://doi.org/10.3390/hemato1020008

Zobrazit plný text záznamu

Relapse from MRD Negativity As Indication for Treatment in Multiple Myeloma - the Remnant Study

Autor: Fredrik Schjesvold, Frida Bugge Askeland, Anne-Marie Rasmussen

Publikováno v: Blood. 136:21-22

Background: Early intervention can reduce the rate of progression and improve overall survival (OS) in smouldering multiple myeloma (SMM) patients (pts) (1, 2). The most powerful predictor of prognosis in active MM is whether pts achieve minimal resi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ec30bd41cdcd42c77c6e3d0933fa5d19
https://doi.org/10.1182/blood-2020-139230

Zobrazit plný text záznamu

A new method for bulk palynological processing of oil-contaminated chalks

Autor: Svend Stouge, Poul Schiøler, Anne-Marie Rasmussen, Ingerlise Nørgaard

INTRODUCTIONThe application of palynomorphs in well-site dating and correlation within the Upper Cretaceous—Danian Chalk Group of the North Sea, is currently being investigated at the Geological Survey of Denmark. Due to the relatively low abundanc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89cd26eb10bc34e658b03795ae977ecf
https://www.j-micropalaeontol.net/10/202/1991/

Zobrazit plný text záznamu

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Autor: Else Marit Inderberg Suso, Einar O. Vik-Mo, Steinar Aamdal, Anne Marie Rasmussen, Gunnar Kvalheim, Gustav Gaudernack, Jan E. Brinchmann, Stein Sæbøe-Larssen, Birthe Viftrup Mikkelsen, Eirik Helseth, Morten C. Moe, Cecilie Sandberg, Knut Lote, Marta Nyakas, Paulina Due-Tönnesen, Iver A. Langmoen

Publikováno v: Cancer Immunology, Immunotherapy

Background The growth and recurrence of several cancers appear to be driven by a population of cancer stem cells (CSCs). Glioblastoma, the most common primary brain tumor, is invariably fatal, with a median survival of approximately 1 year. Although

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f8c9e7a9e86f0c3ae72427b1ca5eaf
http://europepmc.org/articles/PMC3755221

Zobrazit plný text záznamu

Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001

Autor: Anne Marie Rasmussen, Kari Lislerud, Else M. Inderberg-Suso, Gustav Gaudernack, Sissel Trachsel

Publikováno v: Oncoimmunology

Understanding the basis of a successful clinical response after treatment with therapeutic cancer vaccines is essential for the development of more efficacious therapy. After vaccination with the single telomerase (hTERT) 16-mer peptide, GV1001, some

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6785c0ac66e63ab7c20982d0639a271
http://europepmc.org/articles/PMC3429571

Zobrazit plný text záznamu

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

Autor: Carrie J. Markowski, Lasse R. Braathen, Gustav Gaudernack, Kristin Kernland Lang, Mona Møller, Anne Marie Rasmussen, Jon Alm Eriksen, Sissel Trachsel, Robert E. Hunger

Publikováno v: Hunger, Robert E; Kernland Lang, Kristin; Markowski, Carrie J; Trachsel, Sissel; Møller, Mona; Eriksen, Jon A; Rasmussen, Anne-Marie; Braathen, Lasse R; Gaudernack, Gustav (2011). Vaccination of patients with cutaneous melanoma with telomerase-specific peptides. Cancer immunology, immunotherapy, 60(11), pp. 1553-64. Heidelberg: Springer-Verlag 10.1007/s00262-011-1061-z

Purpose: A phase I study was conducted to investigate the safety, tolerability, and immunological responses to vaccination with a combination of telomerase-derived peptides GV1001 (hTERT: 611-626) and p540 (hTERT: 540-548) using granulocyte-macrophag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf4bd877c95f973de2d6b583a5c3252
https://doi.org/10.1007/s00262-011-1061-z

Zobrazit plný text záznamu

hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes

Autor: Turid Vetrhus, Gustav Gaudernack, Steinar Aamdal, Anne Marie Rasmussen, Gunnar Kvalheim, Else Marit Inderberg Suso, Svein Dueland

Publikováno v: Cancer Immunology, Immunotherapy

Immunotherapy targeting the hTERT subunit of telomerase has been shown to induce robust immune responses in cancer patients after vaccination with single hTERT peptides. Vaccination with dendritic cells (DCs) transfected with hTERT mRNA has the poten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa315f1402e247b3cb84bde23cdac7c9
http://europepmc.org/articles/PMC3098983

Zobrazit plný text záznamu

Abstract 4448A: MicroRNA profiling of prostate cancer tissue identifies a prognostic 4-miRNA model and implicates one novel microRNA in prostate cancer cell viability

Autor: Karina Dalsgaard Sørensen, Michael Borre, Jacob Fredsøe, Anne Marie Rasmussen, Helle Kristensen, Linnéa Schmidt, Torben F. Ørntoft, Peter Mouritzen, Søren Svane Hoyer

Publikováno v: Cancer Research. 77:4448A-4448A

Purpose: New prognostic biomarkers for prostate cancer (PC) risk stratification are urgently needed. Here, we identify and validate a novel 4-microRNA prognostic ratio model for prostate cancer. We also identify a new microRNA with tumor suppressive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a0f13e76af0741fb9671354d3c7f9e3d
https://doi.org/10.1158/1538-7445.am2017-4448a

Zobrazit plný text záznamu

Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RIα2C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation

Autor: Finn Olav Levy, Bjørn Steen Skålhegg, Henrik S. Huitfeldt, Steinar Funderud, Erlend B. Smeland, Anne Marie Rasmussen, Kjetil Taskén, Vidar Hansson

Publikováno v: European Journal of Immunology. 26:1290-1296

Cyclic AMP (cAMP) inhibits antigen-stimulated B cell proliferation through activation of cAMP-dependent protein kinases (cAK). We have examined the molecular composition and cellular localization of cAK in human B cells. We find that human B cells co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5608ac5ad11b4ce828bf4b244792dadd
https://doi.org/10.1002/eji.1830260617

Zobrazit plný text záznamu

Abstract 2306: Treatment with hTERT/survivin mRNA-loaded dendritic cells combined with autologous ex vivo expanded T cells improves progression free survival in stage IV melanoma patients when compared to dendritic cell vaccines alone

Autor: Elin Aamdal, Steinar Aamdal, Marianne Lundby, Iris Bigalke, Gustav Gaudernack, Anne Marie Rasmussen, Gunnar Kvalheim, Else Marit Inderberg, Siri Torhaug

Publikováno v: Cancer Research. 76:2306-2306

In previous studies with tumor specific antigen loaded dendritic cells (DCs) we have shown that 50% of patients with metastatic malignant melanoma mount specific immune responses and clinical effects. However responses were only transient. Here we in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c63025dd7229ddc60958eb683528453
https://doi.org/10.1158/1538-7445.am2016-2306

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání